ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2115

Clinical Impact of Acute Symptomatic Vertebral Fractures in the United States: An Observational Study

Neil Binkley1, Michele McDermott2, Eric Yeh2, Joseph Lane3, Jolenta Cheung4, Mona Amet4 and Felicia Cosman5, 1University of Wisconsin, Madison, 2Amgen Inc., Thousand Oaks, 3Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 4Adelphi Real World, Bollington, United Kingdom, 5Columbia University, College of Physicians and Surgeons, New York, NY

Meeting: ACR Convergence 2024

Keywords: Fracture, osteoporosis, pain, quality of life

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: To characterize pain status (frequency, severity, persistency) and effect on activities of daily living (ADLs) in patients with symptomatic vertebral fractures (VF).

Methods: This was an observational, cross-sectional, survey of patients age ≥50 years with ≥1 symptomatic osteoporotic VF within the last 36 weeks (wks) confirmed by spine imaging, recruited from July 2022 to August 2023 at 7 clinical sites across the United States. Data were collected through a one-time patient survey and retrospective medical chart review, and analyzed descriptively. Patients described their pain level and pain characteristics.

Results: Of the 116 patients enrolled, most were postmenopausal women (83%), white (92%), and ≥60 years of age (95%); 37% of patients were recruited within 12 wks, 40% within >12-24 wks, and 23% within >24-36 wks of having a symptomatic VF. Index VF was confirmed by x-ray (60%), MRI (50%), and/or CT scan (37%).

As shown in Fig 1A, within the first 12 wks of an acute symptomatic VF, pain was reported as constant/steady by 42% of patients. After 12 wks, the proportion who reported constant/steady pain was lower but still more than 20% in patients who had a VF >24-36 wks earlier; at that time, more than 80% of patients reported at least intermittent pain. 44% reported high pain severity (between 7–10) within the first 12 wks following VF, and 30% and 36% reported high severity at >12-24 wks and >24-36 wks, respectively. The most common movements that increased pain were standing up (55%), bending down (53%), and lifting (42%). In general, patients reported a negative impact of VF on various ADL, with housework and walking being most impacted (Fig 1B).

Conclusion: In this cross-sectional study, back pain persisted and affected ADL in the majority of patients after 24 wks. Even >24-36 wks after a VF, 84% of patients experienced constant/steady or periodic/intermittent pain. ADLs that were difficult to complete required movements that patients often reported as precipitating pain. Acknowledging the study limitations of cross-sectional design and small numbers enrolled at different times from VF, particularly in the >24-36-wk group, these data provide insight into the impact of VF on patients and emphasize the importance of VF prevention.

Supporting image 1


Disclosures: N. Binkley: Amgen, 5, GE Healthcare, 5, Radius, 2, 5; M. McDermott: Amgen, 3, 11; E. Yeh: Amgen, 3, 11; J. Lane: Amgen, 1, BIC, 2, Kuros, 2, Lenoss, 1, Merck, 5, Mesentech, 2, Radius Health, 2, 5, UCB, 1; J. Cheung: Adelphi Real World, 3; M. Amet: Adelphi Real World, 3; F. Cosman: Amgen, 2, 5, 6, Biocon, 2, Curateq, 2, Enterabio, 2, Pfizer, 2, Radius Health, 5, 6, UCB, 2.

To cite this abstract in AMA style:

Binkley N, McDermott M, Yeh E, Lane J, Cheung J, Amet M, Cosman F. Clinical Impact of Acute Symptomatic Vertebral Fractures in the United States: An Observational Study [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/clinical-impact-of-acute-symptomatic-vertebral-fractures-in-the-united-states-an-observational-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-impact-of-acute-symptomatic-vertebral-fractures-in-the-united-states-an-observational-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology